Advertisement
Advertisement

ANAB

ANAB logo

AnaptysBio, Inc. Common Stock

52.10
USD
Sponsored
+0.47
+0.91%
Jun 10, 16:00 UTC -4
Closed
exchange

Pre-Market

52.60

+0.50
+0.97%

ANAB Earnings Reports

Positive Surprise Ratio

ANAB beat 23 of 38 last estimates.

61%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$31.36M
/
-$0.15
Implied change from Q1 26 (Revenue/ EPS)
+22.73%
/
-91.85%
Implied change from Q2 25 (Revenue/ EPS)
+40.88%
/
-88.81%

AnaptysBio, Inc. Common Stock earnings per share and revenue

On May 12, 2026, ANAB reported earnings of -1.84 USD per share (EPS) for Q1 26, missing the estimate of -0.61 USD, resulting in a -198.75% surprise. Revenue reached 25.56 million, compared to an expected 29.55 million, with a -13.52% difference. The market reacted with a +3.54% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 31.36 million USD, implying an decrease of -91.85% EPS, and increase of 22.73% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, AnaptysBio, Inc. Common Stock reported EPS of -$1.84, missing estimates by -198.75%, and revenue of $25.56M, -13.52% below expectations.
The stock price moved up 3.54%, changed from $66.96 before the earnings release to $69.33 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 10 analysts, AnaptysBio, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $31.36M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement